Restricted accessResearch articleFirst published online 2025-12
Cathodal Transcranial Direct Current Stimulation Attenuates Cerebral Ischemia-Reperfusion Injury by Coordinating Mitophagy Inhibition and Nrf2 Activation Against Ferroptosis
Cathodal transcranial direct current stimulation (C-tDCS), a noninvasive physical therapy, has potential neuroprotective effects in acute ischemic stroke. However, the rational timing of its application and the underlying mechanisms remain inadequately understood. This study aims to investigate its neuroprotective effects and the involved mechanisms.
Results:
Our in vivo results indicated that C-tDCS applied during the reperfusion phase but not during the ischemic phase significantly improved neurological outcomes, reduced infarct volume, and mitigated histopathological damage in middle cerebral artery occlusion/reperfusion rats. C-tDCS during the reperfusion phase suppressed ferroptosis, activated nuclear factor erythroid 2-related factor 2 (Nrf2), and inhibited mitophagy. In vitro, the ferroptosis inducer RSL3 negated the protective effects of cathodal direct current stimulation on HT22 neuronal cells subjected to oxygen-glucose deprivation/reoxygenation injury. Furthermore, the Nrf2 inhibitor ML385 and the mitophagy activator FCCP reversed the inhibitory effects of C-tDCS on ferroptosis, with FCCP also affecting Nrf2 activation by C-tDCS.
Innovation and Conclusions:
These results demonstrate that C-tDCS during reperfusion attenuates cerebral ischemia-reperfusion injury by coordinating mitophagy inhibition and Nrf2 activation to counteract ferroptosis, which provides new evidence for its potential translational clinical applications. Antioxid. Redox Signal. 43, 693–708.
CaiC-C, ZhuJ-H, YeL-X, et al.Glycine protects against hypoxic-ischemic brain injury by regulating mitochondria-mediated autophagy via the AMPK pathway. Oxid Med Cell Longev, 2019; 2019:4248529; doi: 10.1155/2019/4248529
2.
ChamorroÁ, LoEH, RenúA, et al.The future of neuroprotection in stroke. J Neurol Neurosurg Psychiatry, 2021; 92(2):129–135; doi: 10.1136/jnnp-2020-324283
3.
ChenY, FanH, WangS, et al.Ferroptosis: A novel therapeutic target for ischemia-reperfusion injury. Front Cell Dev Biol, 2021; 9:688605; doi: 10.3389/fcell.2021.688605
4.
ChengJ, FanY-Q, JiangH-X, et al.Transcranial direct-current stimulation protects against cerebral ischemia-reperfusion injury through regulating cezanne-dependent signaling. Exp Neurol, 2021; 345:113818; doi: 10.1016/j.expneurol.2021.113818
5.
DodsonM, Castro-PortuguezR, ZhangDD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol, 2019; 23:101107; doi: 10.1016/j.redox.2019.101107
6.
FeiginVL, OwolabiMO. and World Stroke Organization–Lancet Neurology Commission Stroke Collaboration Group. Pragmatic solutions to reduce the global burden of stroke: A world stroke organization-lancet neurology commission. Lancet Neurol, 2023; 22(12):1160–1206; doi: 10.1016/S1474-4422(23)00277-6
7.
GuoH, ZhuL, TangP, et al.Carthamin yellow improves cerebral ischemia-reperfusion injury by attenuating inflammation and ferroptosis in rats. Int J Mol Med, 2021; 47(4):52; doi: 10.3892/ijmm.2021.4885
8.
HuY, LuoY, ZhengY. Nrf2 pathway and autophagy crosstalk: New insights into therapeutic strategies for ischemic cerebral vascular diseases. Antioxidants (Basel), 2022; 11(9):1747; doi: 10.3390/antiox11091747
9.
HuangJ, XueS, BuchmannP, et al.An electrogenetic interface to program mammalian gene expression by direct current. Nat Metab, 2023; 5(8):1395–1407; doi: 10.1038/s42255-023-00850-7
10.
JeongEJ, ChoiJJ, LeeSY, et al.The effects of ML385 on head and neck squamous cell carcinoma: Implications for NRF2 inhibition as a therapeutic strategy. Int J Mol Sci, 2024; 25(13):7011; doi: 10.3390/ijms25137011
11.
KaviannejadR, KarimianSM, RiahiE, et al.Using dual polarities of transcranial direct current stimulation in global cerebral ischemia and its following reperfusion period attenuates neuronal injury. Metab Brain Dis, 2022; 37(5):1503–1516; doi: 10.1007/s11011-022-00985-8
12.
KongX, YaoX, RenJ, et al.tDCS regulates ASBT-3-OxoLCA-PLOD2-PTEN signaling pathway to confer neuroprotection following rat cerebral ischemia-reperfusion injury. Mol Neurobiol, 2023; 60(11):6715–6730; doi: 10.1007/s12035-023-03504-7
13.
LiJ, JiaY-C, DingY-X, et al.The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci, 2023; 19(9):2756–2771; doi: 10.7150/ijbs.83348
14.
LiJ, LiM, GeY, et al.β-Amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood-brain barrier destruction in alzheimer’s disease. Cell Biosci, 2022a;12(1):69; doi: 10.1186/s13578-022-00807-5
15.
LiM, MengZ, YuS, et al.Baicalein ameliorates cerebral ischemia-reperfusion injury by inhibiting ferroptosis via regulating GPX4/ACSL4/ACSL3 axis. Chem Biol Interact, 2022b;366:110137; doi: 10.1016/j.cbi.2022.110137
16.
LiX, ChenJ, YuanS, et al.Activation of the P62-Keap1-NRF2 pathway protects against ferroptosis in radiation-induced lung injury. Oxid Med Cell Longev, 2022c;2022:8973509; doi: 10.1155/2022/8973509
17.
LiaoW, WangZ, FuZ, et al.P62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway. Free Radic Res, 2019; 53(7):800–814; doi: 10.1080/10715762.2019.1635251
18.
LinQ, LiS, JinH, et al.Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis. Int J Biol Sci, 2023; 19(4):1192–1210; doi: 10.7150/ijbs.80775
19.
LiuH, AnN, WangL, et al.Protective effect of Xingnaojing injection on ferroptosis after cerebral ischemia injury in MCAO rats and SH-SY5Y Cells. J Ethnopharmacol, 2023a;301:115836; doi: 10.1016/j.jep.2022.115836
20.
LiuJ, HuangC, LiuJ, et al.Nrf2 and its dependent autophagy activation cooperatively counteract ferroptosis to alleviate acute liver injury. Pharmacol Res, 2023b;187:106563; doi: 10.1016/j.phrs.2022.106563
21.
LiuY, MiY, WangY, et al.Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice. Phytomedicine, 2023c;113:154729; doi: 10.1016/j.phymed.2023.154729
22.
LongaEZ, WeinsteinPR, CarlsonS, et al.Reversible middle cerebral artery occlusion without Craniectomy in rats. Stroke, 1989; 20(1):84–91; doi: 10.1161/01.str.20.1.84
23.
Peruzzotti-JamettiL, CambiaghiM, BacigaluppiM, et al.Safety and efficacy of transcranial direct current stimulation in acute experimental ischemic stroke. Stroke, 2013; 44(11):3166–3174; doi: 10.1161/STROKEAHA.113.001687
24.
PowersWJ, RabinsteinAA, AckersonT, et al.Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2019; 50(12):e344–e418; doi: 10.1161/STR.0000000000000211
25.
Pruvost-RobieuxE, BenzakounJ, TurcG, et al.Cathodal transcranial direct current stimulation in acute ischemic stroke: Pilot randomized controlled trial. Stroke, 2021; 52(6):1951–1960; doi: 10.1161/STROKEAHA.120.032056
26.
StaggCJ, AntalA, NitscheMA. Physiology of transcranial direct current stimulation. J Ect, 2018; 34(3):144–152; doi: 10.1097/YCT.0000000000000510
27.
StockwellBR, Friedmann AngeliJP, BayirH, et al.Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 2017; 171(2):273–285; doi: 10.1016/j.cell.2017.09.021
SunY-Y, ZhuH-J, ZhaoR-Y, et al.Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice. Redox Biol, 2023; 66:102852; doi: 10.1016/j.redox.2023.102852
30.
SunZ, ZhangC, QuX. Study on direct current stimulation promoting the proliferation of human oral mucosal fibroblasts by activating PTEN/Akt/mTOR signaling pathway. J Oral Maxillofac Surg, 2022; 32(6):336–342.
31.
TuoQ-Z, LiuY, XiangZ, et al.Thrombin induces ACSL4-Dependent ferroptosis during cerebral ischemia/reperfusion. Signal Transduct Target Ther, 2022; 7(1):59; doi: 10.1038/s41392-022-00917-z
32.
WangL, LiuC, WangL, et al.Astragaloside IV mitigates Cerebral Ischaemia-Reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis. Eur J Pharmacol, 2023; 944:175516; doi: 10.1016/j.ejphar.2023.175516
33.
WechslerLR, AdeoyeO, AlemsegedF, et al.; XIIth Stroke Treatment Academic Industry Roundtable. Most promising approaches to improve stroke outcomes: The stroke treatment academic industry roundtable XII workshop. Stroke, 2023; 54(12):3202–3213; doi: 10.1161/STROKEAHA.123.044279
34.
YanH-F, TuoQ-Z, YinQ-Z, et al.The pathological role of ferroptosis in ischemia/reperfusion-related injury. Zool Res, 2020; 41(3):220–230; doi: 10.24272/j.issn.2095-8137.2020.042
35.
YuF, ZhangQ, LiuH, et al.Dynamic O-GlcNAcylation coordinates Ferritinophagy and Mitophagy to activate ferroptosis. Cell Discov, 2022; 8(1):40; doi: 10.1038/s41421-022-00390-6
36.
ZhangY-N, WuQ, ZhangN-N, et al.Ischemic preconditioning alleviates cerebral ischemia-reperfusion injury by interfering With Glycocalyx. Transl Stroke Res, 2023; 14(6):929–940; doi: 10.1007/s12975-022-01081-w
37.
ZhongW-J, YangX-S, ZhouH, et al.Role of mitophagy in the pathogenesis of stroke: From mechanism to therapy. Oxid Med Cell Longev, 2022; 2022:6232902; doi: 10.1155/2022/6232902
